Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,092)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| RxSight, Inc. | RXST | $4.90 | $203.81M | — | |
| Satellos Bioscience Inc. | MSCL.TO | CA$9.52 | CA$201.98M | — | |
| Cannara Biotech Inc. | LOVE.TO | CA$2.02 | CA$199.54M | 18.4 | — |
| Pro-Dex, Inc. | PDEX | $60.56 | $195.80M | 14.7 | — |
| Cartesian Therapeutics, Inc. | RNAC | $6.42 | $194.24M | — | |
| ProQR Therapeutics N.V. | PRQR | $1.37 | $193.33M | — | |
| ADC Therapeutics SA | ADCT | $1.50 | $191.50M | — | |
| Exagen Inc. | XGN | $7.88 | $190.90M | — | |
| Invivyd, Inc. | IVVD | $0.64 | $188.44M | — | |
| PepGen Inc. | PEPG | $2.72 | $188.14M | — | |
| Yarrow Bioscience Inc | YARW | $20.17 | $187.67M | — | — |
| Evommune, Inc. | EVMN | $5.17 | $187.63M | — | |
| Compugen Ltd. | CGEN | $2.12 | $187.55M | 5.2 | — |
| Whitehawk Therapeutics, Inc. | WHWK | $3.29 | $187.27M | — | |
| Alpha Cognition Inc. Common Stock | ACOG | $8.58 | $186.85M | — | |
| Precision BioSciences, Inc. | DTIL | $6.71 | $185.21M | — | |
| Eledon Pharmaceuticals, Inc. | ELDN | $2.26 | $183.65M | — | |
| Entrada Therapeutics, Inc. | TRDA | $4.65 | $181.06M | — | |
| Sutro Biopharma, Inc. | STRO | $10.79 | $178.91M | — | |
| Custom Health Holdings Inc. | CHLT.TO | CA$6.15 | CA$178.17M | — | |
| Inogen, Inc. | INGN | $6.67 | $177.01M | — | |
| OptimizeRx Corporation | OPRX | $9.37 | $176.49M | 39.0 | — |
| Innate Pharma S.A. | IPHA | $1.57 | $175.37M | — | |
| Sionna Therapeutics, Inc. | SION | $3.87 | $174.73M | — | |
| Oramed Pharmaceuticals Inc. | ORMP | $4.14 | $172.21M | 1.0 | 6.02% |
| Coherus Oncology, Inc. | CHRS | $1.02 | $165.32M | — | |
| Anbio Biotechnology | NNNN | $3.72 | $163.28M | 24.8 | — |
| Akebia Therapeutics, Inc. | AKBA | $0.59 | $162.19M | — | |
| Adagene Inc. | ADAG | $2.41 | $161.82M | — | |
| NervGen Pharma Corp. | NGEN | $1.50 | $161.28M | — | |
| ALX Oncology Holdings Inc. | ALXO | $1.15 | $159.02M | — | |
| NovaBridge Biosciences | NBP | $1.37 | $158.92M | — | |
| Compass Therapeutics, Inc. | CMPX | $0.81 | $158.30M | — | |
| Medexus Pharmaceuticals Inc. | MDP.TO | CA$4.98 | CA$156.50M | — | |
| MediWound Ltd. | MDWD | $12.10 | $156.21M | — | |
| Jin Medical International Ltd. | ZJYL | $2.09 | $156.12M | 11.0 | — |
| Upstream Bio, Inc. | UPB | $2.80 | $153.36M | — | |
| Neuronetics, Inc. | STIM | $2.01 | $153.16M | — | |
| MaxCyte, Inc. | MXCT | $1.47 | $151.71M | — | |
| Veraxa Biotech AG | VRXA | $1.06 | $149.89M | — | |
| Protara Therapeutics, Inc. | TARA | $2.50 | $147.74M | — | |
| Acumen Pharmaceuticals, Inc. | ABOS | $2.03 | $146.80M | — | |
| Codexis, Inc. | CDXS | $1.29 | $144.55M | — | |
| Jyong Biotech Ltd. | MENS | $1.89 | $143.69M | — | |
| KORU Medical Systems, Inc. | KRMD | $3.11 | $142.85M | — | |
| Molecular Partners AG | MOLN | $3.72 | $142.50M | — | |
| Burning Rock Biotech Limited | BNR | $13.51 | $142.48M | — | |
| Cardiol Therapeutics Inc. | CRDL | $1.17 | $142.17M | — | |
| WW International, Inc. | WW | $14.20 | $141.98M | — | — |
| Canton Strategic Holdings, Inc. | CNTN | $1.93 | $137.85M | — |
RxSight, Inc.
Healthcare / Medical Devices
- Market Cap
- $203.81M
- P/E
- unprofitable
Satellos Bioscience Inc.
Healthcare / Biotechnology
- Market Cap
- CA$201.98M
- P/E
- unprofitable
Cannara Biotech Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$199.54M
- P/E
- 18.4
Pro-Dex, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $195.80M
- P/E
- 14.7
Cartesian Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $194.24M
- P/E
- unprofitable
ProQR Therapeutics N.V.
Healthcare / Biotechnology
- Market Cap
- $193.33M
- P/E
- unprofitable
ADC Therapeutics SA
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $191.50M
- P/E
- unprofitable
Exagen Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $190.90M
- P/E
- unprofitable
Invivyd, Inc.
Healthcare / Biotechnology
- Market Cap
- $188.44M
- P/E
- unprofitable
PepGen Inc.
Healthcare / Biotechnology
- Market Cap
- $188.14M
- P/E
- unprofitable
Yarrow Bioscience Inc
Healthcare / Biotechnology
- Market Cap
- $187.67M
Evommune, Inc.
Healthcare / Biotechnology
- Market Cap
- $187.63M
- P/E
- unprofitable
Compugen Ltd.
Healthcare / Biotechnology
- Market Cap
- $187.55M
- P/E
- 5.2
Whitehawk Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $187.27M
- P/E
- unprofitable
Alpha Cognition Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $186.85M
- P/E
- unprofitable
Precision BioSciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $185.21M
- P/E
- unprofitable
Eledon Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $183.65M
- P/E
- unprofitable
Entrada Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $181.06M
- P/E
- unprofitable
Sutro Biopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $178.91M
- P/E
- unprofitable
Custom Health Holdings Inc.
Healthcare / Health Information Services
- Market Cap
- CA$178.17M
- P/E
- unprofitable
Inogen, Inc.
Healthcare / Medical Devices
- Market Cap
- $177.01M
- P/E
- unprofitable
OptimizeRx Corporation
Healthcare / Health Information Services
- Market Cap
- $176.49M
- P/E
- 39.0
Innate Pharma S.A.
Healthcare / Biotechnology
- Market Cap
- $175.37M
- P/E
- unprofitable
Sionna Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $174.73M
- P/E
- unprofitable
Oramed Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- $172.21M
- P/E
- 1.0
- Dividend Yield
- 6.02%
Coherus Oncology, Inc.
Healthcare / Biotechnology
- Market Cap
- $165.32M
- P/E
- unprofitable
Anbio Biotechnology
Healthcare / Medical Instruments & Supplies
- Market Cap
- $163.28M
- P/E
- 24.8
Akebia Therapeutics, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $162.19M
- P/E
- unprofitable
Adagene Inc.
Healthcare / Biotechnology
- Market Cap
- $161.82M
- P/E
- unprofitable
NervGen Pharma Corp.
Healthcare / Biotechnology
- Market Cap
- $161.28M
- P/E
- unprofitable
ALX Oncology Holdings Inc.
Healthcare / Biotechnology
- Market Cap
- $159.02M
- P/E
- unprofitable
NovaBridge Biosciences
Healthcare / Biotechnology
- Market Cap
- $158.92M
- P/E
- unprofitable
Compass Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $158.30M
- P/E
- unprofitable
Medexus Pharmaceuticals Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- CA$156.50M
- P/E
- unprofitable
MediWound Ltd.
Healthcare / Biotechnology
- Market Cap
- $156.21M
- P/E
- unprofitable
Jin Medical International Ltd.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $156.12M
- P/E
- 11.0
Upstream Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $153.36M
- P/E
- unprofitable
Neuronetics, Inc.
Healthcare / Medical Devices
- Market Cap
- $153.16M
- P/E
- unprofitable
MaxCyte, Inc.
Healthcare / Medical Devices
- Market Cap
- $151.71M
- P/E
- unprofitable
Veraxa Biotech AG
Healthcare / Biotechnology
- Market Cap
- $149.89M
- P/E
- unprofitable
Protara Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $147.74M
- P/E
- unprofitable
Acumen Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $146.80M
- P/E
- unprofitable
Codexis, Inc.
Healthcare / Biotechnology
- Market Cap
- $144.55M
- P/E
- unprofitable
Jyong Biotech Ltd.
Healthcare / Biotechnology
- Market Cap
- $143.69M
- P/E
- unprofitable
KORU Medical Systems, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $142.85M
- P/E
- unprofitable
Molecular Partners AG
Healthcare / Biotechnology
- Market Cap
- $142.50M
- P/E
- unprofitable
Burning Rock Biotech Limited
Healthcare / Diagnostics & Research
- Market Cap
- $142.48M
- P/E
- unprofitable
Cardiol Therapeutics Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $142.17M
- P/E
- unprofitable
WW International, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $141.98M
Canton Strategic Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $137.85M
- P/E
- unprofitable
Showing 601–650 of 1,092 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.